Life Science News

RSS

Massive Genetic Study Explores How Thousands of Variants Shape Personality

A massive genetic study offers one of the clearest pictures yet of how DNA contributes to personality, identifying genetic variants associated with five major personality traits.

24 Oct 2026

Squeezing Cell Nuclei Loosens DNA to Boost CRISPR Reprogramming Efficiency

Our cells hold about two meters of DNA, folded and compacted to fit inside a nucleus far narrower than a strand of human hair.

24 Oct 2026

New RNA Extraction Approaches Overcome Agarose Barriers in Lung Slices

Precision-cut lung slices allow researchers to study living human lung tissue outside the body, preserving the different cell types and structures that make up the organ.

24 Oct 2026

Long-Read Nanopore Sequencing Resolves Unexplained Tumor Mutations

Michigan's Oncology Sequencing Program, or MiOncoSeq, was the first of its kind in the nation to sequence patient tumors.

24 Oct 2026

New Genetic Map Identifies Variations Linked to Long QT Syndrome

Using an innovative, high-throughput technique, an international collaboration led by Vanderbilt Health researchers has created a "map" of 1,757 genetic variations that can trigger a life-threatening heart rhythm disorder called long QT syndrome.

24 Oct 2026

With Climate-Resilient Crops in Mind, Study Tackles Flaw in Photosynthesis

Rising temperatures and increasing drought are shortening crop growing seasons in many parts of the world. Now scientists at KTH report new advances toward engineering more efficient photosynthesis, work that could eventually contribute to efforts to adapt crops for climate change.

24 Oct 2026

Tower Sensing and Genetics Reveal Time-Shifting Phenotypes in Cottonwood Canopies

Black cottonwood is a fast-growing, genetically diverse tree with potential as a lignocellulosic feedstock for biofuels, including sustainable aviation fuels.

24 Oct 2026

Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01

Evaxion A/S, a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, announces new three-year immune and clinical outcome data for personalized cancer vaccine EVX-01 in patients with advanced melanoma.

From Evaxion A/S 24 Oct 2026

Carrier-Free Jet Vaccine Method Protects Against COVID-19 and Flu in Animal Studies

A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way to deliver mRNA vaccines while limiting unwanted inflammation.

24 Oct 2026

Scientists Discover Molecular Cascade Behind Brain Dysregulation in Angelman Syndrome

Angelman syndrome is a rare disease with a single known cause: one missing gene. The lack of that gene, normally inherited from the mother, occurs in approximately one in 20,000 births and is associated with cognitive and mobility deficits that become evident in children when they are around 6 months of age.

24 Oct 2026

Historic Victory for Koalas as Great Koala National Park Legislation Passes NSW Parliament

Conservation groups across New South Wales are celebrating a historic milestone for nature, with legislation to establish the Great Koala National Park passing after more than a decade of campaigning.

24 Oct 2026

Study Highlights New Opportunities for Marine Protection in the Deep Pacific Mining Zone

Scientists discover that adding new ‘stepping stone’ reserves could help transform a patchwork of isolated sanctuaries into a functioning safety-net for marine life, as commercial deep-sea mining moves ever closer.

24 Oct 2026

BioUK Awards 2026 Celebrate Outstanding Achievement and Breakthrough Innovations from Across the Life Sciences

BioUK, the not-for-profit membership organization focused on catalyzing success in UK life sciences, today announced the winners of the 18th annual BioUK Awards following a ceremony hosted at the Royal Lancaster Hotel, London.

From BioUK 23 Oct 2026

Promega UK Launches Lumit ® Insulin Immunoassay

A new homogeneous, wash-free, plate-based assay that enables researchers to rapidly measure insulin secretion using a simple add-and-read format, delivering robust results ideal for metabolic disease drug discovery.

22 Oct 2026

Some Fish Might Thrive in a Warming Climate

Adelaide University researchers have found that some estuarine fishes that live in habitats with highly variable temperatures can withstand the warmer ocean conditions expected to result from climate change.

22 Oct 2026

Genetic Clue to Autism's Fourfold Difference In Boys and Girls

Findings on MECP2 regulatory variants suggest genetic factors contribute to autism's male bias, enhancing understanding of the disorder's heritability.

22 Oct 2026

Accelerating RNA Therapeutics Research with High Throughput Screening

Oligonucleotides have the potential to transform the treatment of a wide range of diseases, and have extensive applications in biomedical research.

From INTEGRA Biosciences 22 Oct 2026

BioNTech Opens mRNA Manufacturing Facility at La Trobe

La Trobe University is now home to one of the world’s leading biopharmaceutical companies, with the official opening of BioNTech’s state-of-the-art, clinical-scale mRNA manufacturing and research facility at the University’s campus in Melbourne’s north.

From BioNTech SE 22 Oct 2026

Eppendorf and BioLabs Expand Collaboration to Support Biotech Innovation in Munich

Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, and BioLabs, a global innovation infrastructure company creating the physical and community backbone that powers life science discovery worldwide, today announced the expansion of their collaboration to BioLabs’ new Munich site, BioLabs | TUM, extending a relationship that already includes BioLabs locations in the U.S, France and Germany.

From Eppendorf SE 22 Oct 2026

INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar

INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to support international access, distribution and commercialization of Ebstrocel™, the Company’s allogeneic stromal cell therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB).

From INmune Bio 22 Oct 2026

Life Science News

Massive Genetic Study Explores How Thousands of Variants Shape Personality

Squeezing Cell Nuclei Loosens DNA to Boost CRISPR Reprogramming Efficiency

New RNA Extraction Approaches Overcome Agarose Barriers in Lung Slices

Long-Read Nanopore Sequencing Resolves Unexplained Tumor Mutations

New Genetic Map Identifies Variations Linked to Long QT Syndrome

With Climate-Resilient Crops in Mind, Study Tackles Flaw in Photosynthesis

Tower Sensing and Genetics Reveal Time-Shifting Phenotypes in Cottonwood Canopies

Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01

Carrier-Free Jet Vaccine Method Protects Against COVID-19 and Flu in Animal Studies

Scientists Discover Molecular Cascade Behind Brain Dysregulation in Angelman Syndrome

Historic Victory for Koalas as Great Koala National Park Legislation Passes NSW Parliament

Study Highlights New Opportunities for Marine Protection in the Deep Pacific Mining Zone

BioUK Awards 2026 Celebrate Outstanding Achievement and Breakthrough Innovations from Across the Life Sciences

Promega UK Launches Lumit ® Insulin Immunoassay

Some Fish Might Thrive in a Warming Climate

Genetic Clue to Autism's Fourfold Difference In Boys and Girls

Accelerating RNA Therapeutics Research with High Throughput Screening

BioNTech Opens mRNA Manufacturing Facility at La Trobe

Eppendorf and BioLabs Expand Collaboration to Support Biotech Innovation in Munich

INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar

The Future of Vision Restoration With ReVision Implant

How a Single List Is Changing Visibility for Women in Science

How Avatar Medical's 3D Technology Is Transforming How We Visualize the Human Body

RecentIndustryFocuses

Editorial Focus eBook - Biopharmaceuticals (2nd edition)

Improving Cell Culture Efficiency with Image-Guided Automation

Improving Scalability in Organoid Research

Cosmetic Formulation and Manufacturing

Latest in Genomics